Skip to content

Clinical trials

Phase 4 Breast Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 4 Country / region: United States Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20031
20042
20054
20061
20074
20086
20092
20102
20113
20122
20131
20142
20151
20163
20172
20182
20193
20202
20213
20225
20233
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting12
Terminated8
Withdrawn7
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center4
Eli Lilly and Company3
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Weill Medical College of Cornell University3
Cancer Center of Irvine2
Novartis2
Thomas Jefferson University2
University of California, San Francisco2
Agendia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms66
Postoperative Pain4
Brain Neoplasms3
Colorectal Neoplasms3
Ovarian Neoplasms3
Bone Diseases, Metabolic2
Breast Carcinoma In Situ2
Head and Neck Neoplasms2
Lymphedema2
Mastodynia2

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.